These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29223436)

  • 1. Predictors of high cost after percutaneous coronary intervention: A review from Japanese multicenter registry overviewing the influence of procedural complications.
    Inohara T; Numasawa Y; Higashi T; Ueda I; Suzuki M; Hayashida K; Yuasa S; Maekawa Y; Fukuda K; Kohsaka S
    Am Heart J; 2017 Dec; 194():61-72. PubMed ID: 29223436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental Cost of Acute Kidney Injury after Percutaneous Coronary Intervention in the United States.
    Amin AP; McNeely C; Spertus JA; Bach RG; Frogge N; Lindner S; Jain S; Bradley SM; Wasfy JH; Goyal A; Maddox T; House JA; Kulkarni H; Masoudi FA
    Am J Cardiol; 2020 Jan; 125(1):29-33. PubMed ID: 31711633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Previous Percutaneous Coronary Intervention Does Not Increase Adverse Events After Coronary Artery Bypass Surgery.
    Ueki C; Miyata H; Motomura N; Sakaguchi G; Akimoto T; Takamoto S
    Ann Thorac Surg; 2017 Jul; 104(1):56-61. PubMed ID: 28131427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of In-Hospital Mortality, Length of Stay, Postprocedural Complications, and Cost of Single-Vessel Versus Multivessel Percutaneous Coronary Intervention in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction (from Nationwide Inpatient Sample [2006 to 2012]).
    Panaich SS; Arora S; Patel N; Schreiber T; Patel NJ; Pandya B; Gupta V; Grines CL; Deshmukh A; Badheka AO
    Am J Cardiol; 2016 Oct; 118(7):950-8. PubMed ID: 27522303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a pre-percutaneous coronary intervention risk model of contrast-induced acute kidney injury with an integer scoring system.
    Inohara T; Kohsaka S; Abe T; Miyata H; Numasawa Y; Ueda I; Nishi Y; Naito K; Shibata M; Hayashida K; Maekawa Y; Kawamura A; Sato Y; Fukuda K
    Am J Cardiol; 2015 Jun; 115(12):1636-42. PubMed ID: 25891989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic burden of complications during percutaneous coronary intervention.
    Jacobson KM; Hall Long K; McMurtry EK; Naessens JM; Rihal CS
    Qual Saf Health Care; 2007 Apr; 16(2):154-9. PubMed ID: 17403766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance and Validation of the U.S. NCDR Acute Kidney Injury Prediction Model in Japan.
    Inohara T; Kohsaka S; Miyata H; Ueda I; Maekawa Y; Fukuda K; Cohen DJ; Kennedy KF; Rumsfeld JS; Spertus JA
    J Am Coll Cardiol; 2016 Apr; 67(14):1715-22. PubMed ID: 27056778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facility-Level Variation in Hospitalization, Mortality, and Costs in the 30 Days After Percutaneous Coronary Intervention: Insights on Short-Term Healthcare Value From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System (VA CART) Program.
    Bradley SM; O'Donnell CI; Grunwald GK; Liu CF; Hebert PL; Maddox TM; Jesse RL; Fihn SD; Rumsfeld JS; Ho PM
    Circulation; 2015 Jul; 132(2):101-8. PubMed ID: 25951833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of percutaneous coronary intervention following recent surgery.
    Hoyt JR; Seth M; Hanson I; Dixon S; Share D; Lalonde T; Wohns D; Moscucci M; Gurm HS
    Am J Cardiol; 2013 Nov; 112(10):1580-5. PubMed ID: 23998350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: data from a large multi-centre Australian registry.
    Ariyaratne TV; Ademi Z; Duffy SJ; Andrianopoulos N; Billah B; Brennan AL; New G; Black A; Ajani AE; Clark DJ; Yan BP; Yap CH; Reid CM
    Int J Cardiol; 2013 Oct; 168(3):2783-90. PubMed ID: 23643437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
    Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDL cholesterol as a novel risk factor for contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.
    Liu YH; Liu Y; Chen JY; Zhou YL; Chen ZJ; Yu DQ; Luo JF; Li HL; He YT; Ye P; Ran P; Guo W; Tan N
    Atherosclerosis; 2014 Dec; 237(2):453-9. PubMed ID: 25463073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
    Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
    Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriateness of elective percutaneous coronary intervention and impact of government health insurance scheme - A tertiary centre experience from Western India.
    Patil D; Lanjewar C; Vaggar G; Bhargava J; Sabnis G; Pahwa J; Phatarpekar A; Shah H; Kerkar P
    Indian Heart J; 2017; 69(5):600-606. PubMed ID: 29054183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Frequency of Acute Kidney Injury in Patients With Renal Transplant Who Underwent Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery.
    Taduru SS; Ramakrishnan M; Mustafa RA; Baweja PS
    Am J Cardiol; 2017 Oct; 120(7):1104-1109. PubMed ID: 28826902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriateness of coronary interventions in Japan by the US and Japanese standards.
    Inohara T; Kohsaka S; Miyata H; Ueda I; Noma S; Suzuki M; Negishi K; Endo A; Nishi Y; Hayashida K; Maekawa Y; Kawamura A; Higashi T; Fukuda K
    Am Heart J; 2014 Dec; 168(6):854-61.e11. PubMed ID: 25458648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Access Site Choice on Acute Kidney Injury After Percutaneous Coronary Intervention.
    Pancholy MS; Skelding K; Scott T; Blankenship J; Pancholy SB
    Am J Cardiol; 2017 Dec; 120(12):2141-2145. PubMed ID: 29100589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the additional costs of clinical complications in patients undergoing transcatheter aortic valve replacement in the German Health Care System.
    Gutmann A; Kaier K; Sorg S; von Zur Mühlen C; Siepe M; Moser M; Geibel A; Zirlik A; Ahrens I; Baumbach H; Beyersdorf F; Vach W; Zehender M; Bode C; Reinöhl J
    Int J Cardiol; 2015 Jan; 179():231-7. PubMed ID: 25464455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention.
    Applegate R; Sacrinty M; Schafer P; Smith J; Gandhi S; Kutcher M; Santos R; Cecile A; Little W
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E375-84. PubMed ID: 23074085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.